Rheumatologic serologies: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
Line 69: Line 69:
 
|-
 
|-
 
|Anti-parietal cell antibodies
 
|Anti-parietal cell antibodies
|[[Autoimmune gastritis]] and [[pernicious anemia]]; also [[Addison disease]], [[autoimmune thyroiditis]], [[type 1 diabetes mellitus]]
+
|[[Autoimmune gastritis]] and [[pernicious anemia]]; also [[Addison disease]], [[autoimmune thyroiditis]], [[type 1 diabetes mellitus]], and [[primary ovarian failure]]
 
|
 
|
 
|}
 
|}

Latest revision as of 11:19, 17 July 2021

Test Association Correlates with dz activity?
ANA SLE No
ANA (centromere pattern) CREST syndrome, SSc, PH
Anti-Smith SLE (most specific) No
Anti-dsDNA SLE Yes, especially renal disease
Anti-histone Drug-induced lupus
Anti-U1-RNP Mixed CTD
Anti-Ro/SS-A Sjögren syndrome, neonatal heart block, subacute SLE
Anti-Ro/SS-A 60 kDa
Anti-Ro/SS-A 52 kDa Systemic sclerosis and SLE, often with other antibodies present1
Anti-La/SSB Sjögren syndrome, sicca syndrome, neonatal SLE
Anti-Scl-70 SSc and pulmonary fibrosis, dcSSc
Anti-Jo-1 Polymyositis, antisynthetase syndrome
Anti-CCP RA (most specific)
Anti-smooth muscle Autoimmune hepatitis
Anti-PR3 (cANCA) GPA
Anti-MPO (pANCA) MPA and eGPA
Anti-parietal cell antibodies Autoimmune gastritis and pernicious anemia; also Addison disease, autoimmune thyroiditis, type 1 diabetes mellitus, and primary ovarian failure

References

  1. ^  B. Hervier, M. Rimbert, F. Colonna, M. A. Hamidou, M. Audrain. Clinical significance of anti-Ro/SSA-52 kDa antibodies--a retrospective monocentric study. Rheumatology. 2009;48(8):964-967. doi:10.1093/rheumatology/kep145.